Cronos Group Inc. Common Share CRON

GlobeNewswire Inc. 10 nov

Duke Robotics Corp. (Nasdaq: DUKR) has entered into a strategic collaboration agreement with CRONOS, a Greek security and technology services company, to commercialize and operate its Insulator Cleaning Drone (IC Drone) technology in Greece. The three-year agreement leverages CRONOS's established presence in Greece's critical infrastructure and energy sectors, with Duke Robotics providing its proprietary IC Drone technology while sharing profits from joint projects, with Duke receiving the majority share. The parties have already identified potential large-scale projects with significant revenue potential.

The Motley Fool 8 nov

An analysis of five major cannabis stocks reveals significant differences in financial health. Cronos Group leads with approximately $841 million in cash and no significant debt, followed closely by SNDL, which is debt-free with positive free cash flow. Tilray and Canopy Growth continue to struggle with debt and negative cash flow despite some revenue growth, while Aurora Cannabis has a smaller liquidity cushion. A strong balance sheet provides financial flexibility but doesn't guarantee profitability or shareholder returns.

Zacks Investment Research 3 nov

Zevra Therapeutics reported Q3 2026 earnings of $0.18 per share, beating consensus estimates of $0.14, with revenues of $37.76 million exceeding expectations by 2.77%. The company has outperformed market estimates in four consecutive quarters. However, the stock received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market. Cronos Group is expected to report Q3 results on November 5, with projected earnings of $0.03 per share, down 57.1% year-over-year, though revenues are expected to grow 30.6%.

Zacks Investment Research 23 oct

Cronos Group (CRON) received an upgrade to Zacks Rank #1 (Strong Buy) based on upward revisions in earnings estimates. The cannabis company has seen analysts steadily raise estimates over the past three months, with consensus estimates increasing 200%. The upgrade positions CRON in the top 5% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation driven by improving business fundamentals.

GlobeNewswire Inc. 15 oct

Cronos Group has completed its acquisition of CanAdelaar B.V., the largest cannabis company in the Netherlands' adult-use cannabis pilot program (Wietexperiment), for a base purchase price of €57.5 million plus contingent cash earnouts. The acquisition establishes Cronos as the market leader in Europe's largest adult-use cannabis market and enables the company to execute its borderless product strategy in the Netherlands with CanAdelaar's proven operational track record and leading market share.